针对有症状的多利科埃克塔斯脊髓瘤的抗TNFα疗法的初步研究
Michael Travis Caton1,2, Kazim Narsinh2, Woody Han2
1Department of Neurosurgery Icahn School of Medicine at Mount Sinai New York NY.
Stroke (Hoboken, N.J.)
|January 26, 2026
概括
抗瘤缩因子α疗法,特别是因弗利西马布,可能会降低多利切切体脊柱动脉瘤 (DVBA) 的生长. 这项初步研究发现,使用infliximab降低了DVBA生长率,没有观察到任何不良事件.
科学领域:
- 神经学 神经学
- 血管外科 血管外科
- 类风湿病学 类风湿病学
背景情况:
- 脊柱动脉瘤 (DVBAs) 具有显著的发病率,治疗选择有限.
- 瘤亡因子α (TNF-α) 途径与DVBA进展有关,但抗TNF-α疗法的作用仍未得到研究.
研究的目的:
- 研究抗TNF-α治疗对DVBA生长和临床结果的影响.
- 在一个病例控制研究中评估因弗利西马布对DVBA进展的影响.
主要方法:
- 对患有DVBAs的患者进行了回顾性病例控制研究.
- 两名患者接受了因风湿性关节炎的因弗利西马布 (TNF-α抑制剂);三名作为对照.
- DVBA的生长被盲目的神经放射学家通过连续MRI/MRA评估.
主要成果:
- 一名接受infliximab治疗的患者显示,DVBA生长速度减少了37%.
- 在infliximab治疗期间,平均DVBA生长率较低 (0.13 mm2/天),而非infliximab治疗期间 (0.50 mm2/天).
- 因弗利克西马布患者保持功能状态 (mRS=1) 没有不良事件,与经历死亡率和不良结果的对照组不同.
结论:
- 因弗利克西马布治疗显示了减少DVBA生长轨迹的潜力.
- 观察到低和减少DVBA增长与infliximab表明一个可能的治疗作用.
- 需要进一步的研究来确认infliximab对DVBA临床结果的影响.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
324
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
324
Aneurysm I: Introduction
403
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
403
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Aneurysm IV: Nursing Management
464
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
464
Group Therapy
417
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
417
Aneurysm III: Interprofessional Care
285
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
285


